nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2D6—Lomustine—brain cancer	0.0922	0.218	CbGbCtD
Mianserin—CYP1A2—Carmustine—brain cancer	0.0912	0.216	CbGbCtD
Mianserin—CYP2D6—Hydroxyurea—brain cancer	0.0698	0.166	CbGbCtD
Mianserin—CYP3A4—Temozolomide—brain cancer	0.0689	0.163	CbGbCtD
Mianserin—CYP3A4—Lomustine—brain cancer	0.0586	0.139	CbGbCtD
Mianserin—CYP1A2—Etoposide—brain cancer	0.027	0.0641	CbGbCtD
Mianserin—HTR1D—meninx—brain cancer	0.0175	0.0625	CbGeAlD
Mianserin—HTR1F—trigeminal nerve—brain cancer	0.0174	0.0624	CbGeAlD
Mianserin—HTR1D—dura mater—brain cancer	0.0161	0.0575	CbGeAlD
Mianserin—CYP3A4—Etoposide—brain cancer	0.0142	0.0336	CbGbCtD
Mianserin—HTR2C—choroid plexus—brain cancer	0.0136	0.0485	CbGeAlD
Mianserin—DRD3—telencephalic ventricle—brain cancer	0.00714	0.0255	CbGeAlD
Mianserin—HTR1D—trigeminal nerve—brain cancer	0.00692	0.0247	CbGeAlD
Mianserin—HTR2A—choroid plexus—brain cancer	0.0068	0.0243	CbGeAlD
Mianserin—HTR1F—ganglion—brain cancer	0.00629	0.0225	CbGeAlD
Mianserin—HRH1—nose—brain cancer	0.00524	0.0188	CbGeAlD
Mianserin—HTR7—vein—brain cancer	0.00498	0.0178	CbGeAlD
Mianserin—HTR1D—cranial nerve—brain cancer	0.00493	0.0176	CbGeAlD
Mianserin—HTR6—ganglion—brain cancer	0.00428	0.0153	CbGeAlD
Mianserin—SLC6A3—telencephalic ventricle—brain cancer	0.00411	0.0147	CbGeAlD
Mianserin—HTR1D—telencephalic ventricle—brain cancer	0.00401	0.0143	CbGeAlD
Mianserin—HTR2C—telencephalic ventricle—brain cancer	0.00397	0.0142	CbGeAlD
Mianserin—HTR7—cranial nerve—brain cancer	0.00393	0.014	CbGeAlD
Mianserin—Lethargy—Lomustine—brain cancer	0.00389	0.0222	CcSEcCtD
Mianserin—HTR7—pons—brain cancer	0.00388	0.0139	CbGeAlD
Mianserin—Bone marrow depression—Hydroxyurea—brain cancer	0.00382	0.0218	CcSEcCtD
Mianserin—HTR2A—trigeminal nerve—brain cancer	0.00344	0.0123	CbGeAlD
Mianserin—HTR2A—cerebellar cortex—brain cancer	0.00342	0.0122	CbGeAlD
Mianserin—HTR1A—telencephalic ventricle—brain cancer	0.00334	0.0119	CbGeAlD
Mianserin—HTR7—telencephalic ventricle—brain cancer	0.00319	0.0114	CbGeAlD
Mianserin—Pancytopenia—Lomustine—brain cancer	0.00313	0.0179	CcSEcCtD
Mianserin—HTR2A—vein—brain cancer	0.00311	0.0111	CbGeAlD
Mianserin—DRD2—telencephalic ventricle—brain cancer	0.00302	0.0108	CbGeAlD
Mianserin—Gynaecomastia—Procarbazine—brain cancer	0.00298	0.017	CcSEcCtD
Mianserin—Hepatic function abnormal—Procarbazine—brain cancer	0.00277	0.0158	CcSEcCtD
Mianserin—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00273	0.0156	CcSEcCtD
Mianserin—SLC6A3—ganglion—brain cancer	0.00256	0.00914	CbGeAlD
Mianserin—HTR1D—ganglion—brain cancer	0.0025	0.00892	CbGeAlD
Mianserin—HTR2C—ganglion—brain cancer	0.00247	0.00884	CbGeAlD
Mianserin—Lethargy—Procarbazine—brain cancer	0.00247	0.0141	CcSEcCtD
Mianserin—HTR2A—cranial nerve—brain cancer	0.00245	0.00876	CbGeAlD
Mianserin—HTR1F—telencephalon—brain cancer	0.00243	0.00868	CbGeAlD
Mianserin—HTR2A—pons—brain cancer	0.00242	0.00865	CbGeAlD
Mianserin—Diplopia—Procarbazine—brain cancer	0.00242	0.0138	CcSEcCtD
Mianserin—SLC6A4—ganglion—brain cancer	0.00234	0.00838	CbGeAlD
Mianserin—Hepatic enzyme increased—Temozolomide—brain cancer	0.00213	0.0122	CcSEcCtD
Mianserin—HTR1A—ganglion—brain cancer	0.00208	0.00744	CbGeAlD
Mianserin—SLC6A2—ganglion—brain cancer	0.00206	0.00737	CbGeAlD
Mianserin—Leukopenia—Lomustine—brain cancer	0.00205	0.0117	CcSEcCtD
Mianserin—HTR2A—telencephalic ventricle—brain cancer	0.00199	0.00712	CbGeAlD
Mianserin—HTR7—ganglion—brain cancer	0.00199	0.00711	CbGeAlD
Mianserin—Pancytopenia—Procarbazine—brain cancer	0.00199	0.0113	CcSEcCtD
Mianserin—HTR1D—blood vessel—brain cancer	0.00198	0.0071	CbGeAlD
Mianserin—SLC6A3—hindbrain—brain cancer	0.00194	0.00693	CbGeAlD
Mianserin—DRD2—ganglion—brain cancer	0.00188	0.00672	CbGeAlD
Mianserin—Gynaecomastia—Carmustine—brain cancer	0.00187	0.0107	CcSEcCtD
Mianserin—Drowsiness—Procarbazine—brain cancer	0.00186	0.0106	CcSEcCtD
Mianserin—Thrombocytopenia—Lomustine—brain cancer	0.00183	0.0105	CcSEcCtD
Mianserin—Jaundice—Procarbazine—brain cancer	0.00182	0.0104	CcSEcCtD
Mianserin—SLC6A4—hindbrain—brain cancer	0.00178	0.00635	CbGeAlD
Mianserin—HTR2A—pineal body—brain cancer	0.00173	0.00618	CbGeAlD
Mianserin—HTR7—endothelium—brain cancer	0.00171	0.00613	CbGeAlD
Mianserin—Breast disorder—Hydroxyurea—brain cancer	0.00169	0.00966	CcSEcCtD
Mianserin—HTR6—telencephalon—brain cancer	0.00165	0.0059	CbGeAlD
Mianserin—Nasal congestion—Temozolomide—brain cancer	0.00161	0.00917	CcSEcCtD
Mianserin—HTR7—blood vessel—brain cancer	0.00158	0.00565	CbGeAlD
Mianserin—HTR1A—hindbrain—brain cancer	0.00158	0.00564	CbGeAlD
Mianserin—Pancytopenia—Hydroxyurea—brain cancer	0.00154	0.00878	CcSEcCtD
Mianserin—Diplopia—Carmustine—brain cancer	0.00151	0.00865	CcSEcCtD
Mianserin—Neutropenia—Hydroxyurea—brain cancer	0.00151	0.00864	CcSEcCtD
Mianserin—HTR1F—head—brain cancer	0.00151	0.0054	CbGeAlD
Mianserin—HTR7—hindbrain—brain cancer	0.00151	0.00539	CbGeAlD
Mianserin—Weight increased—Hydroxyurea—brain cancer	0.00147	0.00841	CcSEcCtD
Mianserin—Diplopia—Temozolomide—brain cancer	0.00146	0.00835	CcSEcCtD
Mianserin—Cyclizine—CYP2C9—brain cancer	0.00146	0.312	CrCbGaD
Mianserin—Drowsiness—Hydroxyurea—brain cancer	0.00144	0.00824	CcSEcCtD
Mianserin—DRD2—hindbrain—brain cancer	0.00143	0.0051	CbGeAlD
Mianserin—HTR1F—central nervous system—brain cancer	0.00138	0.00493	CbGeAlD
Mianserin—Tremor—Procarbazine—brain cancer	0.00137	0.0078	CcSEcCtD
Mianserin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00136	0.00779	CcSEcCtD
Mianserin—Anaemia—Procarbazine—brain cancer	0.00135	0.00769	CcSEcCtD
Mianserin—Breast disorder—Temozolomide—brain cancer	0.00132	0.00755	CcSEcCtD
Mianserin—Syncope—Procarbazine—brain cancer	0.00131	0.00746	CcSEcCtD
Mianserin—Leukopenia—Procarbazine—brain cancer	0.0013	0.00745	CcSEcCtD
Mianserin—Loss of consciousness—Procarbazine—brain cancer	0.00128	0.00731	CcSEcCtD
Mianserin—Convulsion—Procarbazine—brain cancer	0.00126	0.00721	CcSEcCtD
Mianserin—Hypertension—Procarbazine—brain cancer	0.00126	0.00718	CcSEcCtD
Mianserin—Pancytopenia—Carmustine—brain cancer	0.00124	0.0071	CcSEcCtD
Mianserin—Myalgia—Procarbazine—brain cancer	0.00124	0.00708	CcSEcCtD
Mianserin—Arthralgia—Procarbazine—brain cancer	0.00124	0.00708	CcSEcCtD
Mianserin—HTR2A—ganglion—brain cancer	0.00124	0.00443	CbGeAlD
Mianserin—Neutropenia—Carmustine—brain cancer	0.00122	0.00699	CcSEcCtD
Mianserin—Dry mouth—Procarbazine—brain cancer	0.00121	0.00693	CcSEcCtD
Mianserin—Pancytopenia—Temozolomide—brain cancer	0.0012	0.00686	CcSEcCtD
Mianserin—Cardiac failure—Etoposide—brain cancer	0.0012	0.00685	CcSEcCtD
Mianserin—Confusional state—Procarbazine—brain cancer	0.0012	0.00685	CcSEcCtD
Mianserin—Oedema—Procarbazine—brain cancer	0.00119	0.00679	CcSEcCtD
Mianserin—Neutropenia—Temozolomide—brain cancer	0.00118	0.00675	CcSEcCtD
Mianserin—Mirtazapine—CYP2C9—brain cancer	0.00118	0.252	CrCbGaD
Mianserin—Angiopathy—Hydroxyurea—brain cancer	0.00118	0.00671	CcSEcCtD
Mianserin—Shock—Procarbazine—brain cancer	0.00117	0.00668	CcSEcCtD
Mianserin—Erectile dysfunction—Temozolomide—brain cancer	0.00116	0.00665	CcSEcCtD
Mianserin—Thrombocytopenia—Procarbazine—brain cancer	0.00116	0.00665	CcSEcCtD
Mianserin—Tachycardia—Procarbazine—brain cancer	0.00116	0.00663	CcSEcCtD
Mianserin—Weight increased—Temozolomide—brain cancer	0.00115	0.00657	CcSEcCtD
Mianserin—Cardiac arrest—Etoposide—brain cancer	0.00111	0.00636	CcSEcCtD
Mianserin—SLC6A3—brainstem—brain cancer	0.00111	0.00397	CbGeAlD
Mianserin—Hypotension—Procarbazine—brain cancer	0.00111	0.00635	CcSEcCtD
Mianserin—HTR1F—brain—brain cancer	0.0011	0.00392	CbGeAlD
Mianserin—HTR1D—brainstem—brain cancer	0.00108	0.00388	CbGeAlD
Mianserin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00108	0.00619	CcSEcCtD
Mianserin—HTR2C—brainstem—brain cancer	0.00107	0.00384	CbGeAlD
Mianserin—HTR2A—endothelium—brain cancer	0.00107	0.00382	CbGeAlD
Mianserin—Paraesthesia—Procarbazine—brain cancer	0.00107	0.0061	CcSEcCtD
Mianserin—DRD3—head—brain cancer	0.00107	0.00382	CbGeAlD
Mianserin—Hepatobiliary disease—Temozolomide—brain cancer	0.00107	0.00609	CcSEcCtD
Mianserin—Somnolence—Procarbazine—brain cancer	0.00106	0.00604	CcSEcCtD
Mianserin—Anaemia—Hydroxyurea—brain cancer	0.00104	0.00595	CcSEcCtD
Mianserin—Connective tissue disorder—Carmustine—brain cancer	0.00103	0.00588	CcSEcCtD
Mianserin—HTR6—head—brain cancer	0.00103	0.00367	CbGeAlD
Mianserin—Fatigue—Procarbazine—brain cancer	0.00103	0.00586	CcSEcCtD
Mianserin—SLC6A4—brainstem—brain cancer	0.00102	0.00364	CbGeAlD
Mianserin—Constipation—Procarbazine—brain cancer	0.00102	0.00581	CcSEcCtD
Mianserin—Hepatitis—Temozolomide—brain cancer	0.00101	0.00578	CcSEcCtD
Mianserin—Leukopenia—Hydroxyurea—brain cancer	0.00101	0.00577	CcSEcCtD
Mianserin—Connective tissue disorder—Temozolomide—brain cancer	0.000994	0.00568	CcSEcCtD
Mianserin—SLC6A3—telencephalon—brain cancer	0.000986	0.00353	CbGeAlD
Mianserin—HTR2A—blood vessel—brain cancer	0.000986	0.00352	CbGeAlD
Mianserin—Feeling abnormal—Procarbazine—brain cancer	0.00098	0.0056	CcSEcCtD
Mianserin—Eye disorder—Carmustine—brain cancer	0.000979	0.00559	CcSEcCtD
Mianserin—Convulsion—Hydroxyurea—brain cancer	0.000977	0.00558	CcSEcCtD
Mianserin—DRD3—central nervous system—brain cancer	0.000974	0.00348	CbGeAlD
Mianserin—HTR1D—telencephalon—brain cancer	0.000963	0.00344	CbGeAlD
Mianserin—Pancytopenia—Etoposide—brain cancer	0.000961	0.00549	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000953	0.00545	CcSEcCtD
Mianserin—HTR2C—telencephalon—brain cancer	0.000953	0.00341	CbGeAlD
Mianserin—HRH2—endocrine gland—brain cancer	0.000951	0.0034	CbGeAlD
Mianserin—OPRK1—head—brain cancer	0.000951	0.0034	CbGeAlD
Mianserin—Neutropenia—Etoposide—brain cancer	0.000946	0.0054	CcSEcCtD
Mianserin—Eye disorder—Temozolomide—brain cancer	0.000946	0.0054	CcSEcCtD
Mianserin—Tinnitus—Temozolomide—brain cancer	0.000944	0.00539	CcSEcCtD
Mianserin—HTR2A—hindbrain—brain cancer	0.00094	0.00336	CbGeAlD
Mianserin—Cardiac disorder—Temozolomide—brain cancer	0.000939	0.00536	CcSEcCtD
Mianserin—HRH2—head—brain cancer	0.000939	0.00336	CbGeAlD
Mianserin—HTR6—central nervous system—brain cancer	0.000938	0.00335	CbGeAlD
Mianserin—Oedema—Hydroxyurea—brain cancer	0.00092	0.00526	CcSEcCtD
Mianserin—Angiopathy—Temozolomide—brain cancer	0.000918	0.00524	CcSEcCtD
Mianserin—Mental disorder—Carmustine—brain cancer	0.000917	0.00524	CcSEcCtD
Mianserin—Mediastinal disorder—Temozolomide—brain cancer	0.000912	0.00521	CcSEcCtD
Mianserin—HTR1A—brainstem—brain cancer	0.000904	0.00323	CbGeAlD
Mianserin—SLC6A4—telencephalon—brain cancer	0.000904	0.00323	CbGeAlD
Mianserin—Nervous system disorder—Hydroxyurea—brain cancer	0.000903	0.00515	CcSEcCtD
Mianserin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000901	0.00515	CcSEcCtD
Mianserin—SLC6A2—brainstem—brain cancer	0.000897	0.00321	CbGeAlD
Mianserin—HTR2B—telencephalon—brain cancer	0.000895	0.0032	CbGeAlD
Mianserin—Skin disorder—Hydroxyurea—brain cancer	0.000894	0.00511	CcSEcCtD
Mianserin—Mental disorder—Temozolomide—brain cancer	0.000887	0.00506	CcSEcCtD
Mianserin—Jaundice—Etoposide—brain cancer	0.000879	0.00502	CcSEcCtD
Mianserin—OPRK1—central nervous system—brain cancer	0.000868	0.0031	CbGeAlD
Mianserin—HTR7—brainstem—brain cancer	0.000864	0.00309	CbGeAlD
Mianserin—HRH2—central nervous system—brain cancer	0.000857	0.00307	CbGeAlD
Mianserin—CYP2D6—hindbrain—brain cancer	0.000856	0.00306	CbGeAlD
Mianserin—Tremor—Carmustine—brain cancer	0.000854	0.00488	CcSEcCtD
Mianserin—Asthenia—Procarbazine—brain cancer	0.000853	0.00487	CcSEcCtD
Mianserin—Hepatobiliary disease—Etoposide—brain cancer	0.000853	0.00487	CcSEcCtD
Mianserin—OPRK1—cerebellum—brain cancer	0.000849	0.00303	CbGeAlD
Mianserin—Anaemia—Carmustine—brain cancer	0.000843	0.00481	CcSEcCtD
Mianserin—Agranulocytosis—Etoposide—brain cancer	0.000842	0.00481	CcSEcCtD
Mianserin—Pruritus—Procarbazine—brain cancer	0.000841	0.00481	CcSEcCtD
Mianserin—Agitation—Carmustine—brain cancer	0.000838	0.00478	CcSEcCtD
Mianserin—Tremor—Temozolomide—brain cancer	0.000825	0.00471	CcSEcCtD
Mianserin—Somnolence—Hydroxyurea—brain cancer	0.000818	0.00467	CcSEcCtD
Mianserin—DRD2—brainstem—brain cancer	0.000817	0.00292	CbGeAlD
Mianserin—Leukopenia—Carmustine—brain cancer	0.000816	0.00466	CcSEcCtD
Mianserin—Anaemia—Temozolomide—brain cancer	0.000814	0.00465	CcSEcCtD
Mianserin—Agitation—Temozolomide—brain cancer	0.00081	0.00462	CcSEcCtD
Mianserin—HTR1A—telencephalon—brain cancer	0.000802	0.00287	CbGeAlD
Mianserin—SLC6A2—telencephalon—brain cancer	0.000796	0.00284	CbGeAlD
Mianserin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000795	0.00454	CcSEcCtD
Mianserin—Fatigue—Hydroxyurea—brain cancer	0.000793	0.00453	CcSEcCtD
Mianserin—Vertigo—Temozolomide—brain cancer	0.000791	0.00452	CcSEcCtD
Mianserin—Convulsion—Carmustine—brain cancer	0.00079	0.00451	CcSEcCtD
Mianserin—Leukopenia—Temozolomide—brain cancer	0.000789	0.0045	CcSEcCtD
Mianserin—Hypertension—Carmustine—brain cancer	0.000787	0.0045	CcSEcCtD
Mianserin—Constipation—Hydroxyurea—brain cancer	0.000787	0.00449	CcSEcCtD
Mianserin—Dizziness—Procarbazine—brain cancer	0.000786	0.00449	CcSEcCtD
Mianserin—Myalgia—Carmustine—brain cancer	0.000776	0.00443	CcSEcCtD
Mianserin—DRD3—brain—brain cancer	0.000773	0.00277	CbGeAlD
Mianserin—Nortriptyline—CYP2C9—brain cancer	0.000772	0.165	CrCbGaD
Mianserin—HTR7—telencephalon—brain cancer	0.000767	0.00274	CbGeAlD
Mianserin—Convulsion—Temozolomide—brain cancer	0.000763	0.00436	CcSEcCtD
Mianserin—Hypertension—Temozolomide—brain cancer	0.000761	0.00434	CcSEcCtD
Mianserin—Feeling abnormal—Hydroxyurea—brain cancer	0.000758	0.00433	CcSEcCtD
Mianserin—Eye disorder—Etoposide—brain cancer	0.000757	0.00432	CcSEcCtD
Mianserin—Cardiac disorder—Etoposide—brain cancer	0.000752	0.00429	CcSEcCtD
Mianserin—Confusional state—Carmustine—brain cancer	0.00075	0.00428	CcSEcCtD
Mianserin—Myalgia—Temozolomide—brain cancer	0.00075	0.00428	CcSEcCtD
Mianserin—Arthralgia—Temozolomide—brain cancer	0.00075	0.00428	CcSEcCtD
Mianserin—Rash—Procarbazine—brain cancer	0.00075	0.00428	CcSEcCtD
Mianserin—Dermatitis—Procarbazine—brain cancer	0.000749	0.00428	CcSEcCtD
Mianserin—HTR2C—medulla oblongata—brain cancer	0.000749	0.00268	CbGeAlD
Mianserin—Headache—Procarbazine—brain cancer	0.000745	0.00425	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000745	0.00425	CcSEcCtD
Mianserin—HTR6—brain—brain cancer	0.000744	0.00266	CbGeAlD
Mianserin—Oedema—Carmustine—brain cancer	0.000744	0.00425	CcSEcCtD
Mianserin—Angiopathy—Etoposide—brain cancer	0.000735	0.0042	CcSEcCtD
Mianserin—Dry mouth—Temozolomide—brain cancer	0.000733	0.00419	CcSEcCtD
Mianserin—Mediastinal disorder—Etoposide—brain cancer	0.00073	0.00417	CcSEcCtD
Mianserin—Thrombocytopenia—Carmustine—brain cancer	0.000728	0.00416	CcSEcCtD
Mianserin—Trimipramine—CYP2C9—brain cancer	0.000727	0.156	CrCbGaD
Mianserin—Tachycardia—Carmustine—brain cancer	0.000726	0.00415	CcSEcCtD
Mianserin—DRD2—telencephalon—brain cancer	0.000725	0.00259	CbGeAlD
Mianserin—Confusional state—Temozolomide—brain cancer	0.000725	0.00414	CcSEcCtD
Mianserin—Oedema—Temozolomide—brain cancer	0.000719	0.00411	CcSEcCtD
Mianserin—SLC6A3—midbrain—brain cancer	0.000708	0.00253	CbGeAlD
Mianserin—Nervous system disorder—Temozolomide—brain cancer	0.000705	0.00403	CcSEcCtD
Mianserin—ADRA2C—telencephalon—brain cancer	0.000705	0.00252	CbGeAlD
Mianserin—Thrombocytopenia—Temozolomide—brain cancer	0.000704	0.00402	CcSEcCtD
Mianserin—Skin disorder—Temozolomide—brain cancer	0.000698	0.00399	CcSEcCtD
Mianserin—Hypotension—Carmustine—brain cancer	0.000695	0.00397	CcSEcCtD
Mianserin—HTR1D—midbrain—brain cancer	0.000691	0.00247	CbGeAlD
Mianserin—SLC6A3—spinal cord—brain cancer	0.000691	0.00247	CbGeAlD
Mianserin—OPRK1—brain—brain cancer	0.000689	0.00246	CbGeAlD
Mianserin—HTR2C—midbrain—brain cancer	0.000685	0.00245	CbGeAlD
Mianserin—HRH2—brain—brain cancer	0.000681	0.00243	CbGeAlD
Mianserin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000678	0.00387	CcSEcCtD
Mianserin—Paraesthesia—Carmustine—brain cancer	0.000668	0.00382	CcSEcCtD
Mianserin—HTR2C—spinal cord—brain cancer	0.000668	0.00239	CbGeAlD
Mianserin—SLC6A2—gonad—brain cancer	0.000664	0.00237	CbGeAlD
Mianserin—Somnolence—Carmustine—brain cancer	0.000661	0.00378	CcSEcCtD
Mianserin—Asthenia—Hydroxyurea—brain cancer	0.00066	0.00377	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000655	0.00374	CcSEcCtD
Mianserin—Anaemia—Etoposide—brain cancer	0.000652	0.00372	CcSEcCtD
Mianserin—SLC6A4—midbrain—brain cancer	0.000649	0.00232	CbGeAlD
Mianserin—Paraesthesia—Temozolomide—brain cancer	0.000646	0.00369	CcSEcCtD
Mianserin—Gastrointestinal disorder—Carmustine—brain cancer	0.000642	0.00367	CcSEcCtD
Mianserin—HTR7—gonad—brain cancer	0.00064	0.00229	CbGeAlD
Mianserin—Somnolence—Temozolomide—brain cancer	0.000639	0.00365	CcSEcCtD
Mianserin—Constipation—Carmustine—brain cancer	0.000636	0.00363	CcSEcCtD
Mianserin—Vertigo—Etoposide—brain cancer	0.000633	0.00362	CcSEcCtD
Mianserin—SLC6A4—spinal cord—brain cancer	0.000633	0.00226	CbGeAlD
Mianserin—Leukopenia—Etoposide—brain cancer	0.000631	0.0036	CcSEcCtD
Mianserin—SLC6A2—medulla oblongata—brain cancer	0.000625	0.00224	CbGeAlD
Mianserin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000621	0.00355	CcSEcCtD
Mianserin—Fatigue—Temozolomide—brain cancer	0.00062	0.00354	CcSEcCtD
Mianserin—Loss of consciousness—Etoposide—brain cancer	0.00062	0.00354	CcSEcCtD
Mianserin—Constipation—Temozolomide—brain cancer	0.000615	0.00351	CcSEcCtD
Mianserin—SLC6A3—head—brain cancer	0.000614	0.0022	CbGeAlD
Mianserin—Feeling abnormal—Carmustine—brain cancer	0.000613	0.0035	CcSEcCtD
Mianserin—Convulsion—Etoposide—brain cancer	0.000611	0.00349	CcSEcCtD
Mianserin—Hypertension—Etoposide—brain cancer	0.000609	0.00348	CcSEcCtD
Mianserin—Dizziness—Hydroxyurea—brain cancer	0.000609	0.00348	CcSEcCtD
Mianserin—HTR7—medulla oblongata—brain cancer	0.000603	0.00215	CbGeAlD
Mianserin—HTR1D—head—brain cancer	0.000599	0.00214	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000596	0.0034	CcSEcCtD
Mianserin—HTR2C—head—brain cancer	0.000594	0.00212	CbGeAlD
Mianserin—Feeling abnormal—Temozolomide—brain cancer	0.000592	0.00338	CcSEcCtD
Mianserin—DRD2—pituitary gland—brain cancer	0.00059	0.00211	CbGeAlD
Mianserin—Rash—Hydroxyurea—brain cancer	0.00058	0.00331	CcSEcCtD
Mianserin—Confusional state—Etoposide—brain cancer	0.00058	0.00331	CcSEcCtD
Mianserin—Dermatitis—Hydroxyurea—brain cancer	0.00058	0.00331	CcSEcCtD
Mianserin—Headache—Hydroxyurea—brain cancer	0.000577	0.00329	CcSEcCtD
Mianserin—HTR1A—midbrain—brain cancer	0.000576	0.00206	CbGeAlD
Mianserin—ADRA2C—pituitary gland—brain cancer	0.000574	0.00205	CbGeAlD
Mianserin—HRH1—telencephalon—brain cancer	0.000573	0.00205	CbGeAlD
Mianserin—SLC6A4—endocrine gland—brain cancer	0.00057	0.00204	CbGeAlD
Mianserin—Thrombocytopenia—Etoposide—brain cancer	0.000563	0.00322	CcSEcCtD
Mianserin—SLC6A4—head—brain cancer	0.000563	0.00201	CbGeAlD
Mianserin—ADRA2A—telencephalon—brain cancer	0.000562	0.00201	CbGeAlD
Mianserin—HTR1A—spinal cord—brain cancer	0.000562	0.00201	CbGeAlD
Mianserin—Tachycardia—Etoposide—brain cancer	0.000561	0.00321	CcSEcCtD
Mianserin—SLC6A3—central nervous system—brain cancer	0.000561	0.002	CbGeAlD
Mianserin—Skin disorder—Etoposide—brain cancer	0.000559	0.00319	CcSEcCtD
Mianserin—HTR2B—head—brain cancer	0.000558	0.00199	CbGeAlD
Mianserin—ADRA2C—medulla oblongata—brain cancer	0.000554	0.00198	CbGeAlD
Mianserin—HTR7—midbrain—brain cancer	0.000551	0.00197	CbGeAlD
Mianserin—SLC6A3—cerebellum—brain cancer	0.000548	0.00196	CbGeAlD
Mianserin—HTR1D—central nervous system—brain cancer	0.000547	0.00196	CbGeAlD
Mianserin—HTR2C—central nervous system—brain cancer	0.000542	0.00194	CbGeAlD
Mianserin—HTR2A—brainstem—brain cancer	0.000539	0.00193	CbGeAlD
Mianserin—Hypotension—Etoposide—brain cancer	0.000538	0.00307	CcSEcCtD
Mianserin—HTR7—spinal cord—brain cancer	0.000537	0.00192	CbGeAlD
Mianserin—Amitriptyline—CYP2C9—brain cancer	0.000536	0.115	CrCbGaD
Mianserin—Asthenia—Carmustine—brain cancer	0.000534	0.00305	CcSEcCtD
Mianserin—DRD2—midbrain—brain cancer	0.000521	0.00186	CbGeAlD
Mianserin—Paraesthesia—Etoposide—brain cancer	0.000517	0.00295	CcSEcCtD
Mianserin—Asthenia—Temozolomide—brain cancer	0.000516	0.00295	CcSEcCtD
Mianserin—SLC6A4—central nervous system—brain cancer	0.000514	0.00184	CbGeAlD
Mianserin—Somnolence—Etoposide—brain cancer	0.000511	0.00292	CcSEcCtD
Mianserin—HTR2B—central nervous system—brain cancer	0.000509	0.00182	CbGeAlD
Mianserin—Pruritus—Temozolomide—brain cancer	0.000509	0.00291	CcSEcCtD
Mianserin—ADRA2C—midbrain—brain cancer	0.000506	0.00181	CbGeAlD
Mianserin—HTR1A—endocrine gland—brain cancer	0.000506	0.00181	CbGeAlD
Mianserin—SLC6A2—endocrine gland—brain cancer	0.000502	0.00179	CbGeAlD
Mianserin—HTR1A—head—brain cancer	0.0005	0.00179	CbGeAlD
Mianserin—Gastrointestinal disorder—Etoposide—brain cancer	0.000497	0.00284	CcSEcCtD
Mianserin—Fatigue—Etoposide—brain cancer	0.000496	0.00283	CcSEcCtD
Mianserin—SLC6A2—head—brain cancer	0.000495	0.00177	CbGeAlD
Mianserin—ADRA2C—spinal cord—brain cancer	0.000494	0.00177	CbGeAlD
Mianserin—Dizziness—Carmustine—brain cancer	0.000492	0.00281	CcSEcCtD
Mianserin—Constipation—Etoposide—brain cancer	0.000492	0.00281	CcSEcCtD
Mianserin—CYP2D6—brainstem—brain cancer	0.000491	0.00176	CbGeAlD
Mianserin—CYP2B6—gonad—brain cancer	0.000489	0.00175	CbGeAlD
Mianserin—HTR7—endocrine gland—brain cancer	0.000484	0.00173	CbGeAlD
Mianserin—HTR2A—telencephalon—brain cancer	0.000478	0.00171	CbGeAlD
Mianserin—HTR7—head—brain cancer	0.000478	0.00171	CbGeAlD
Mianserin—Dizziness—Temozolomide—brain cancer	0.000475	0.00272	CcSEcCtD
Mianserin—Feeling abnormal—Etoposide—brain cancer	0.000474	0.00271	CcSEcCtD
Mianserin—ADRA2A—gonad—brain cancer	0.000469	0.00168	CbGeAlD
Mianserin—Rash—Carmustine—brain cancer	0.000469	0.00268	CcSEcCtD
Mianserin—Dermatitis—Carmustine—brain cancer	0.000469	0.00268	CcSEcCtD
Mianserin—Headache—Carmustine—brain cancer	0.000466	0.00266	CcSEcCtD
Mianserin—ADRA2A—pituitary gland—brain cancer	0.000458	0.00164	CbGeAlD
Mianserin—DRD2—endocrine gland—brain cancer	0.000457	0.00164	CbGeAlD
Mianserin—HTR1A—central nervous system—brain cancer	0.000456	0.00163	CbGeAlD
Mianserin—Rash—Temozolomide—brain cancer	0.000453	0.00259	CcSEcCtD
Mianserin—Dermatitis—Temozolomide—brain cancer	0.000453	0.00259	CcSEcCtD
Mianserin—SLC6A2—central nervous system—brain cancer	0.000452	0.00162	CbGeAlD
Mianserin—DRD2—head—brain cancer	0.000451	0.00161	CbGeAlD
Mianserin—Headache—Temozolomide—brain cancer	0.00045	0.00257	CcSEcCtD
Mianserin—HTR1A—cerebellum—brain cancer	0.000446	0.00159	CbGeAlD
Mianserin—SLC6A3—brain—brain cancer	0.000445	0.00159	CbGeAlD
Mianserin—ADRA2A—medulla oblongata—brain cancer	0.000442	0.00158	CbGeAlD
Mianserin—ADRA2C—head—brain cancer	0.000439	0.00157	CbGeAlD
Mianserin—HTR7—central nervous system—brain cancer	0.000436	0.00156	CbGeAlD
Mianserin—CYP2D6—telencephalon—brain cancer	0.000436	0.00156	CbGeAlD
Mianserin—HTR1D—brain—brain cancer	0.000434	0.00155	CbGeAlD
Mianserin—HTR2C—brain—brain cancer	0.00043	0.00154	CbGeAlD
Mianserin—HTR7—cerebellum—brain cancer	0.000426	0.00152	CbGeAlD
Mianserin—Asthenia—Etoposide—brain cancer	0.000413	0.00236	CcSEcCtD
Mianserin—DRD2—central nervous system—brain cancer	0.000412	0.00147	CbGeAlD
Mianserin—SLC6A4—brain—brain cancer	0.000408	0.00146	CbGeAlD
Mianserin—Pruritus—Etoposide—brain cancer	0.000407	0.00232	CcSEcCtD
Mianserin—HTR2B—brain—brain cancer	0.000404	0.00144	CbGeAlD
Mianserin—ADRA2A—midbrain—brain cancer	0.000404	0.00144	CbGeAlD
Mianserin—DRD2—cerebellum—brain cancer	0.000403	0.00144	CbGeAlD
Mianserin—ADRA2C—central nervous system—brain cancer	0.000401	0.00143	CbGeAlD
Mianserin—HTR2A—gonad—brain cancer	0.000399	0.00143	CbGeAlD
Mianserin—ADRA2A—spinal cord—brain cancer	0.000394	0.00141	CbGeAlD
Mianserin—ADRA2C—cerebellum—brain cancer	0.000392	0.0014	CbGeAlD
Mianserin—HTR2A—pituitary gland—brain cancer	0.000389	0.00139	CbGeAlD
Mianserin—CYP1A2—endocrine gland—brain cancer	0.000386	0.00138	CbGeAlD
Mianserin—Dizziness—Etoposide—brain cancer	0.00038	0.00217	CcSEcCtD
Mianserin—HTR2A—medulla oblongata—brain cancer	0.000376	0.00134	CbGeAlD
Mianserin—CYP2B6—endocrine gland—brain cancer	0.00037	0.00132	CbGeAlD
Mianserin—CYP2B6—head—brain cancer	0.000365	0.00131	CbGeAlD
Mianserin—Rash—Etoposide—brain cancer	0.000363	0.00207	CcSEcCtD
Mianserin—Dermatitis—Etoposide—brain cancer	0.000362	0.00207	CcSEcCtD
Mianserin—HTR1A—brain—brain cancer	0.000362	0.00129	CbGeAlD
Mianserin—HRH1—endocrine gland—brain cancer	0.000361	0.00129	CbGeAlD
Mianserin—Headache—Etoposide—brain cancer	0.00036	0.00206	CcSEcCtD
Mianserin—SLC6A2—brain—brain cancer	0.000359	0.00128	CbGeAlD
Mianserin—HRH1—head—brain cancer	0.000357	0.00127	CbGeAlD
Mianserin—ADRA2A—endocrine gland—brain cancer	0.000355	0.00127	CbGeAlD
Mianserin—ADRA2A—head—brain cancer	0.00035	0.00125	CbGeAlD
Mianserin—HTR7—brain—brain cancer	0.000346	0.00124	CbGeAlD
Mianserin—HTR2A—midbrain—brain cancer	0.000343	0.00123	CbGeAlD
Mianserin—HTR2A—spinal cord—brain cancer	0.000335	0.0012	CbGeAlD
Mianserin—CYP2B6—central nervous system—brain cancer	0.000333	0.00119	CbGeAlD
Mianserin—DRD2—brain—brain cancer	0.000327	0.00117	CbGeAlD
Mianserin—HRH1—central nervous system—brain cancer	0.000325	0.00116	CbGeAlD
Mianserin—ADRA2A—central nervous system—brain cancer	0.00032	0.00114	CbGeAlD
Mianserin—ADRA2C—brain—brain cancer	0.000318	0.00114	CbGeAlD
Mianserin—ADRA2A—cerebellum—brain cancer	0.000312	0.00112	CbGeAlD
Mianserin—HTR2A—endocrine gland—brain cancer	0.000302	0.00108	CbGeAlD
Mianserin—HTR2A—head—brain cancer	0.000298	0.00106	CbGeAlD
Mianserin—CYP3A4—endocrine gland—brain cancer	0.000279	0.000998	CbGeAlD
Mianserin—CYP2D6—endocrine gland—brain cancer	0.000275	0.000982	CbGeAlD
Mianserin—HTR2A—central nervous system—brain cancer	0.000272	0.000972	CbGeAlD
Mianserin—CYP2D6—head—brain cancer	0.000271	0.00097	CbGeAlD
Mianserin—HTR2A—cerebellum—brain cancer	0.000266	0.00095	CbGeAlD
Mianserin—CYP2B6—brain—brain cancer	0.000265	0.000946	CbGeAlD
Mianserin—HRH1—brain—brain cancer	0.000258	0.000924	CbGeAlD
Mianserin—ADRA2A—brain—brain cancer	0.000254	0.000907	CbGeAlD
Mianserin—CYP3A4—central nervous system—brain cancer	0.000252	0.0009	CbGeAlD
Mianserin—CYP2D6—central nervous system—brain cancer	0.000248	0.000885	CbGeAlD
Mianserin—CYP2D6—cerebellum—brain cancer	0.000242	0.000865	CbGeAlD
Mianserin—HTR2A—brain—brain cancer	0.000216	0.000772	CbGeAlD
Mianserin—CYP2D6—brain—brain cancer	0.000197	0.000703	CbGeAlD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.85e-05	0.000155	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.82e-05	0.000153	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HES1—brain cancer	1.82e-05	0.000153	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.81e-05	0.000153	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IRS2—brain cancer	1.8e-05	0.000152	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.8e-05	0.000152	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SPP1—brain cancer	1.8e-05	0.000152	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—TP53—brain cancer	1.79e-05	0.000151	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.79e-05	0.000151	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—BSG—brain cancer	1.78e-05	0.00015	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.78e-05	0.00015	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.76e-05	0.000148	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—VEGFA—brain cancer	1.74e-05	0.000147	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SPP1—brain cancer	1.74e-05	0.000146	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MYC—brain cancer	1.73e-05	0.000146	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—EGFR—brain cancer	1.73e-05	0.000146	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.73e-05	0.000146	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SPP1—brain cancer	1.73e-05	0.000146	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—STAT3—brain cancer	1.72e-05	0.000145	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL2—brain cancer	1.72e-05	0.000145	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.72e-05	0.000145	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL2—brain cancer	1.71e-05	0.000144	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—APC—brain cancer	1.71e-05	0.000144	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.71e-05	0.000144	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—EGFR—brain cancer	1.71e-05	0.000144	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—EGFR—brain cancer	1.71e-05	0.000144	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—EGFR—brain cancer	1.7e-05	0.000143	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—EGFR—brain cancer	1.7e-05	0.000143	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.68e-05	0.000142	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CCND1—brain cancer	1.68e-05	0.000141	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CTNNB1—brain cancer	1.66e-05	0.00014	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL2—brain cancer	1.65e-05	0.000139	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HES1—brain cancer	1.65e-05	0.000139	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL2—brain cancer	1.64e-05	0.000138	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IRS2—brain cancer	1.63e-05	0.000137	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HES1—brain cancer	1.62e-05	0.000137	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HES1—brain cancer	1.62e-05	0.000136	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.62e-05	0.000136	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CG—brain cancer	1.61e-05	0.000135	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MYC—brain cancer	1.6e-05	0.000135	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.6e-05	0.000135	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—IL2—brain cancer	1.6e-05	0.000135	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—APC—brain cancer	1.59e-05	0.000134	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.59e-05	0.000134	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.57e-05	0.000132	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.000132	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IRS2—brain cancer	1.57e-05	0.000132	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ENO2—brain cancer	1.57e-05	0.000132	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—IL2—brain cancer	1.57e-05	0.000132	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—EGFR—brain cancer	1.57e-05	0.000132	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IRS2—brain cancer	1.56e-05	0.000132	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.56e-05	0.000131	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.55e-05	0.00013	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.54e-05	0.00013	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—IDH1—brain cancer	1.53e-05	0.000129	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SPP1—brain cancer	1.53e-05	0.000128	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.52e-05	0.000128	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SPP1—brain cancer	1.5e-05	0.000126	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SPP1—brain cancer	1.5e-05	0.000126	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—RELA—brain cancer	1.49e-05	0.000125	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HES1—brain cancer	1.48e-05	0.000124	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—ERBB2—brain cancer	1.48e-05	0.000124	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—RELA—brain cancer	1.46e-05	0.000123	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—RELA—brain cancer	1.46e-05	0.000123	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—VEGFA—brain cancer	1.46e-05	0.000123	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—ERBB2—brain cancer	1.46e-05	0.000123	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—ERBB2—brain cancer	1.45e-05	0.000122	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—brain cancer	1.45e-05	0.000122	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—RELA—brain cancer	1.45e-05	0.000122	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.000122	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—EGFR—brain cancer	1.45e-05	0.000122	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—STAT3—brain cancer	1.45e-05	0.000122	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.44e-05	0.000122	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—APC—brain cancer	1.44e-05	0.000121	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.44e-05	0.000121	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.43e-05	0.00012	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL2—brain cancer	1.43e-05	0.00012	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL2—brain cancer	1.43e-05	0.00012	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—brain cancer	1.42e-05	0.00012	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.41e-05	0.000118	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—APC—brain cancer	1.39e-05	0.000117	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.39e-05	0.000117	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.38e-05	0.000116	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—APC—brain cancer	1.38e-05	0.000116	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000116	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.37e-05	0.000115	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IRS2—brain cancer	1.36e-05	0.000114	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IRS2—brain cancer	1.35e-05	0.000114	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MYC—brain cancer	1.35e-05	0.000113	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.34e-05	0.000113	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—APC—brain cancer	1.34e-05	0.000113	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL2—brain cancer	1.34e-05	0.000113	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—RELA—brain cancer	1.34e-05	0.000113	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.33e-05	0.000112	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL2—brain cancer	1.32e-05	0.000111	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL2—brain cancer	1.32e-05	0.000111	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—EGFR—brain cancer	1.32e-05	0.000111	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—brain cancer	1.31e-05	0.000111	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.31e-05	0.00011	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL2—brain cancer	1.31e-05	0.00011	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CCND1—brain cancer	1.3e-05	0.00011	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CG—brain cancer	1.3e-05	0.00011	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.3e-05	0.000109	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CTNNB1—brain cancer	1.29e-05	0.000109	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CCND1—brain cancer	1.29e-05	0.000108	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCND1—brain cancer	1.28e-05	0.000108	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCND1—brain cancer	1.28e-05	0.000107	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.27e-05	0.000107	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.27e-05	0.000107	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.26e-05	0.000106	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.26e-05	0.000106	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.26e-05	0.000106	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—RELA—brain cancer	1.24e-05	0.000105	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ERBB2—brain cancer	1.24e-05	0.000104	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.24e-05	0.000104	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.22e-05	0.000103	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CG—brain cancer	1.22e-05	0.000103	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APC—brain cancer	1.22e-05	0.000103	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.000103	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ENO2—brain cancer	1.21e-05	0.000102	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL2—brain cancer	1.2e-05	0.000101	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APC—brain cancer	1.2e-05	0.000101	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.2e-05	0.000101	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.2e-05	0.000101	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APC—brain cancer	1.2e-05	0.000101	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCND1—brain cancer	1.17e-05	9.89e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.16e-05	9.79e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—brain cancer	1.14e-05	9.58e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—STAT3—brain cancer	1.13e-05	9.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—RELA—brain cancer	1.12e-05	9.46e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—brain cancer	1.12e-05	9.44e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL2—brain cancer	1.12e-05	9.44e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—brain cancer	1.12e-05	9.43e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.12e-05	9.4e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.11e-05	9.37e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—STAT3—brain cancer	1.11e-05	9.35e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—EGFR—brain cancer	1.11e-05	9.35e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—STAT3—brain cancer	1.11e-05	9.34e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—brain cancer	1.1e-05	9.3e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—STAT3—brain cancer	1.1e-05	9.28e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCND1—brain cancer	1.09e-05	9.2e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.09e-05	9.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APC—brain cancer	1.09e-05	9.18e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.09e-05	9.18e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—EGFR—brain cancer	1.09e-05	9.18e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—RELA—brain cancer	1.08e-05	9.13e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.08e-05	9.11e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—RELA—brain cancer	1.08e-05	9.08e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.08e-05	9.07e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.07e-05	9.03e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—RELA—brain cancer	1.05e-05	8.84e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MYC—brain cancer	1.05e-05	8.81e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ERBB2—brain cancer	1.04e-05	8.78e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MYC—brain cancer	1.03e-05	8.69e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MYC—brain cancer	1.03e-05	8.68e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EGFR—brain cancer	1.02e-05	8.62e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MYC—brain cancer	1.02e-05	8.62e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—brain cancer	1.02e-05	8.62e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—STAT3—brain cancer	1.01e-05	8.53e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2—brain cancer	1.01e-05	8.52e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EGFR—brain cancer	1.01e-05	8.5e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EGFR—brain cancer	1.01e-05	8.49e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EGFR—brain cancer	1e-05	8.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—EGFR—brain cancer	9.94e-06	8.37e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCND1—brain cancer	9.86e-06	8.3e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	9.77e-06	8.22e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2—brain cancer	9.77e-06	8.22e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2—brain cancer	9.72e-06	8.18e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—brain cancer	9.52e-06	8.02e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—RELA—brain cancer	9.52e-06	8.02e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCND1—brain cancer	9.52e-06	8.02e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCND1—brain cancer	9.47e-06	7.98e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB2—brain cancer	9.46e-06	7.97e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2—brain cancer	9.45e-06	7.96e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—brain cancer	9.43e-06	7.94e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CTNNB1—brain cancer	9.43e-06	7.94e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—brain cancer	9.42e-06	7.93e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CTNNB1—brain cancer	9.38e-06	7.9e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—RELA—brain cancer	9.37e-06	7.89e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—RELA—brain cancer	9.35e-06	7.87e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB2—brain cancer	9.31e-06	7.84e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB2—brain cancer	9.29e-06	7.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCND1—brain cancer	9.21e-06	7.76e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EGFR—brain cancer	9.21e-06	7.76e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	9.12e-06	7.68e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—brain cancer	8.76e-06	7.38e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—brain cancer	8.6e-06	7.24e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—brain cancer	8.6e-06	7.24e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—brain cancer	8.57e-06	7.22e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—brain cancer	8.57e-06	7.22e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RELA—brain cancer	8.52e-06	7.18e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—brain cancer	8.51e-06	7.17e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CG—brain cancer	8.5e-06	7.16e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—brain cancer	8.47e-06	7.13e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—brain cancer	8.47e-06	7.13e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—brain cancer	8.46e-06	7.13e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—brain cancer	8.44e-06	7.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—brain cancer	8.42e-06	7.09e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—brain cancer	8.41e-06	7.08e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCND1—brain cancer	8.36e-06	7.04e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—brain cancer	8.3e-06	6.99e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CTNNB1—brain cancer	8.28e-06	6.97e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—brain cancer	8.26e-06	6.95e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCND1—brain cancer	8.22e-06	6.93e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—brain cancer	8.22e-06	6.92e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCND1—brain cancer	8.21e-06	6.91e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—brain cancer	8.18e-06	6.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CTNNB1—brain cancer	8.14e-06	6.86e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CTNNB1—brain cancer	8.13e-06	6.84e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—brain cancer	8.03e-06	6.76e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—brain cancer	7.95e-06	6.7e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—brain cancer	7.91e-06	6.66e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—brain cancer	7.74e-06	6.52e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—brain cancer	7.73e-06	6.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—brain cancer	7.68e-06	6.46e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—brain cancer	7.64e-06	6.43e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—brain cancer	7.6e-06	6.4e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCND1—brain cancer	7.48e-06	6.3e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—brain cancer	7.47e-06	6.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—brain cancer	7.43e-06	6.26e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	7.41e-06	6.24e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—brain cancer	7.39e-06	6.22e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—brain cancer	7.29e-06	6.14e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—brain cancer	7.23e-06	6.09e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—brain cancer	7.22e-06	6.08e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CG—brain cancer	7.2e-06	6.06e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—brain cancer	7.2e-06	6.06e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—brain cancer	7.17e-06	6.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—brain cancer	7.15e-06	6.02e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—brain cancer	7.1e-06	5.98e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—brain cancer	7.08e-06	5.97e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—brain cancer	6.7e-06	5.65e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—brain cancer	6.6e-06	5.56e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—brain cancer	6.58e-06	5.54e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—brain cancer	6.56e-06	5.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—brain cancer	6.52e-06	5.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—brain cancer	6.5e-06	5.47e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—brain cancer	6.46e-06	5.44e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—brain cancer	6.45e-06	5.43e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—brain cancer	6.44e-06	5.42e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—brain cancer	6.27e-06	5.28e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—brain cancer	6.24e-06	5.25e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—brain cancer	6.07e-06	5.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—brain cancer	6e-06	5.05e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.87e-06	4.94e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CG—brain cancer	5.56e-06	4.68e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—brain cancer	5.51e-06	4.64e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—brain cancer	5.42e-06	4.56e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—brain cancer	5.41e-06	4.55e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—brain cancer	4.93e-06	4.15e-05	CbGpPWpGaD
